Our customer services representatives are available 24 hours a day, from Monday to Sunday.
CONTACT USSuccinyl cyclodextrins (SuCDs) are chemically modified cyclodextrins (CDs) that are functionalized with succinyl groups for specific pharmaceutical applications. They are succinylated derivatives of natural CDs with enhanced aqueous solubility, molecular recognition properties, and biocompatibility. CDs are cyclic oligosaccharides consisting of α-(1→4)-linked glucopyranose units with a hydrophobic central cavity and a hydrophilic exterior. This structure allows them to form host–guest inclusion complexes with a variety of poorly water-soluble drugs. Succinyl cyclodextrins are CDs functionalized with succinyl groups attached to the hydroxyl groups present on the CD backbone. The introduction of succinyl groups significantly changes the physicochemical and biological properties of these carriers. SuCDs can be used in sophisticated drug delivery systems.
Fig.1 Structure of succinyl cyclodextrin.
Alfa Chemistry offers succinylated derivatives of CDs, including Succinyl-α-CD (SACD), Succinyl-β-CD (SBCD), Succinyl-γ-CD (SuGCD), hydroxypropylated analogs (SuHPBCD, SuHPGCD). They are used in drug formulation, enzyme inhibition, nanotechnology, and chiral separation. Their superior solubilization and encapsulation properties enable improved bioavailability, targeted drug delivery, and controlled release systems.
| Catalog | Product Name | Inquiry |
| CD-DR04 | Succinyl-Alpha-Cyclodextrin | Inquiry |
| CD-DR05 | Succinyl-Beta-Cyclodextrin | Inquiry |
| CD-DR06 | Succinyl-Gamma-Cyclodextrin | Inquiry |
| CD-DR15 | Succinyl-(2-Hydroxypropyl)-Beta Cyclodextrin | Inquiry |
| CD-DR16 | Succinyl-(2-Hydroxypropyl)-gamma cyclodextrin | Inquiry |
Table: Comparison of Key Succinyl Cyclodextrin Derivatives
| Compound | Cavity Size | Solubility | Ideal Applications |
| Succinyl-α-CD (SACD) | Small | Moderate | Hydrophobic small molecule solubilization |
| Succinyl-β-CD (SBCD) | Medium | High | Oral drug formulations, chiral separations |
| Succinyl-γ-CD (SuGCD) | Large | Very High | Protein/peptide encapsulation, nanoparticle base |
| SuHPBCD | Medium | Very High | Injectable drugs, systemic delivery |
| SuHPGCD | Large | Very High | Gene and protein delivery, targeted release |
Enhanced Solubilizing Capacity: Succinyl substitution provides carboxylate functionalities that can further improve water solubility and ionization capacity of the parent CD. This can lead to a marked improvement in the solubilizing capacity of cyclodextrins for hydrophobic drugs. For example, Succinyl-β-CD (SBCD) was found to form strong inclusion complexes with a wide range of APIs, significantly improving their dissolution rate and in vivo absorption. Additionally, the amphiphilic nature of these derivatives can facilitate improved membrane permeability and reduced drug crystallization, enabling favorable pharmacokinetic properties.
Fig.2 Study on the inclusion complex of albendazole (ABZ) in succinyl-β-cyclodextrin with two degrees of substitution[1].
Mucoadhesion and Physiological Stability: The presence of succinyl groups also imparts mucoadhesion and stability in physiological conditions, which is particularly advantageous for oral, pulmonary, and parenteral drug delivery. SuHPBCD and SuHPGCD with additional hydroxypropyl substitution can provide a further enhanced balance between hydrophilicity and complexation efficiency, enabling tunable drug loading and release kinetics.
Fabrication of Nanocarriers: In the context of nanomedicine, succinylated CDs have been extensively utilized for the fabrication of nanocarriers such as chitosan/SBCD nanoparticles and protein-loaded nanospheres. These systems have exhibited excellent biocompatibility, encapsulation efficiency, and controlled release behavior. For example, SBCD-based nanoparticles were reported to enable significant improvement in the sustained release of bovine serum albumin (BSA) as a model protein drug carrier.
Site-Specific Delivery and pH Responsiveness: Incorporation of SuCDs in nanoparticle matrices can not only improve solubility but also impart pH-responsive properties, given the ionizable nature of the succinyl groups. These properties can be exploited for site-specific drug delivery, such as tumor-targeted drug release and intracellular delivery.
Fig.3 Schematic diagram of the preparation of cyclodextrin nanoparticles by cross-linking succinyl-β-cyclodextrin with L-lysine catalyzed by EDC/NHS, followed by fluorescent derivatization with the succinimidyl ester of AF555[2].
Some succinyl derivatives are known to act as enzyme inhibitors, for example, succinyl acetone, is a competitive inhibitor of δ-aminolevulinic acid dehydratase, and its use results in the disruption of heme biosynthesis. This mechanism is being exploited in clinical trials for the treatment of hereditary tyrosinemia type I.
SuCDs are also finding applications as enzyme modulators and stabilizers, with studies showing improved enzymatic selectivity and catalysis in biologically relevant environments.
Chiral recognition is an important aspect of the development of pure enantiomers of drug candidates. SuBCDs have been shown to outperform many other CD derivatives such as carboxymethyl-β-CD (in terms of efficacy) in certain chiral separations, attributed to the higher number of hydrogen bonding and electrostatic interactions in such complexes. These separation methodologies have been used in capillary electrophoresis and HPLC-based chiral separations, in which SUCDs showed superior peak symmetry and resolution compared to other CDs.
Fig.4 Catechins were separated by capillary electrophoresis using mono-, di- and trisuccinyl-b-cyclodextrin as chiral selectors. (a) Structures of (6)-catechin and succinyl-b-cyclodextrins.(b) Dependence of the chiral separation of (6)-catechin at pH 9.8 on the nature and concentration of Suc-β-CDs[3].
Succinyl CDs are utilized in diverse dosage forms including oral tablets, injectables, and inhalable formulations. Their ability to form inclusion complexes with insoluble drugs enhances formulation flexibility and stability. Moreover, their high water solubility ensures minimal toxicity and favorable pharmacodynamics. SuHPBCD, for example, is frequently used in parenteral preparations due to its low nephrotoxicity and excellent drug complexation capacity.
Alfa Chemistry provides pharmaceutical-grade SuCDs produced under GMP-compliant conditions for both R&D and commercial-scale manufacturing. We also offer custom synthesis for clients looking for particular substitution patterns or functionalized CD scaffolds for their specific applications.
SuCDs have also found applications outside of pharmaceutical applications, some of which include:
Fig.5 Succinyl-β-cyclodextrin modified gold biochip to improve the sensitivity of Lyme disease serum immunoassay. The CD-modified biochip platform has a stronger affinity for VlsE protein[4].
1. How do succinyl cyclodextrins differ from hydroxypropyl or methylated cyclodextrins?
Succinyl CD derivatives have carboxyl functional groups that confer pH sensitivity and ionic character, making them suitable for stimuli-responsive drug delivery, unlike neutral hydroxypropyl or methylated CDs.
2. Can succinyl cyclodextrins be used in injectable formulations?
Yes. Especially SuHPBCD and SBCD, which demonstrate excellent water solubility, low toxicity, and compatibility with various APIs for parenteral administration.
3. What determines the degree of substitution (DS) in succinyl CDs, and why does it matter?
DS refers to the average number of succinyl groups per cyclodextrin molecule. A higher DS generally increases water solubility and complexation ability, but may reduce binding specificity.
4. Are succinyl cyclodextrins biodegradable or metabolically inert?
They are considered non-toxic and largely excreted unchanged in urine. However, the exact metabolic fate depends on the degree of substitution and administration route.
5. Do SuCDs work for peptide or protein delivery?
Yes. SuCD-based nanoparticles have been proven to encapsulate and slowly release proteins like BSA, suggesting strong potential in protein or peptide therapeutics.
Alfa Chemistry's extensive collection of cyclodextrin derivatives delivers custom solutions for research and industrial needs across the globe.
References
It should be noted that our our products and services are for research use only, not for clinical use.
Privacy Policy | Cookie Policy | Copyright © 2026 Alfa Chemistry. All rights reserved.